208 related articles for article (PubMed ID: 29577459)
1. Astragaloside IV reverses MNNG-induced precancerous lesions of gastric carcinoma in rats: Regulation on glycolysis through miRNA-34a/LDHA pathway.
Zhang C; Cai T; Zeng X; Cai D; Chen Y; Huang X; Gan H; Zhuo J; Zhao Z; Pan H; Li S
Phytother Res; 2018 Jul; 32(7):1364-1372. PubMed ID: 29577459
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of Weipixiao decoction against MNNG-induced gastric precancerous lesions in rats.
Cai T; Zhang C; Zeng X; Zhao Z; Yan Y; Yu X; Wu L; Lin L; Pan H
Biomed Pharmacother; 2019 Dec; 120():109427. PubMed ID: 31648165
[TBL] [Abstract][Full Text] [Related]
3. The gastric mucosal protective effects of astragaloside IV in mnng-induced GPL rats.
Cai T; Zhang C; Zhao Z; Li S; Cai H; Chen X; Cai D; Liu W; Yan Y; Xie K; Pan H; Zeng X
Biomed Pharmacother; 2018 Aug; 104():291-299. PubMed ID: 29775897
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
[TBL] [Abstract][Full Text] [Related]
5. Weipixiao attenuate early angiogenesis in rats with gastric precancerous lesions.
Zeng J; Yan R; Pan H; You F; Cai T; Liu W; Zheng C; Zhao Z; Gong D; Chen L; Zhang Y
BMC Complement Altern Med; 2018 Sep; 18(1):250. PubMed ID: 30200948
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κB signaling pathway.
Lu M; Tang F; Zhang J; Luan A; Mei M; Xu C; Zhang S; Wang H; Maslov LN
Phytother Res; 2015 Apr; 29(4):599-606. PubMed ID: 25604645
[TBL] [Abstract][Full Text] [Related]
7. Xiao Tan He Wei Decoction reverses MNNG-induced precancerous lesions of gastric carcinoma in vivo and vitro: Regulation of apoptosis through NF-κB pathway.
Xu J; Shen W; Pei B; Wang X; Sun D; Li Y; Xiu L; Liu X; Lu Y; Zhang X; Yue X
Biomed Pharmacother; 2018 Dec; 108():95-102. PubMed ID: 30218863
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV protects blood-brain barrier integrity from LPS-induced disruption via activating Nrf2 antioxidant signaling pathway in mice.
Li H; Wang P; Huang F; Jin J; Wu H; Zhang B; Wang Z; Shi H; Wu X
Toxicol Appl Pharmacol; 2018 Feb; 340():58-66. PubMed ID: 29294303
[TBL] [Abstract][Full Text] [Related]
9. Gastro-Protective Effects of Calycosin Against Precancerous Lesions of Gastric Carcinoma in Rats.
Li D; Zhao L; Li Y; Kang X; Zhang S
Drug Des Devel Ther; 2020; 14():2207-2219. PubMed ID: 32606591
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-κB pathways.
Xu C; Tang F; Lu M; Yang J; Han R; Mei M; Hu J; Zhou M; Wang H
Int Immunopharmacol; 2016 Apr; 33():119-27. PubMed ID: 26903414
[TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV alleviates lipopolysaccharide-induced preeclampsia-like phenotypes via suppressing the inflammatory responses.
Tuerxun D; Aierken R; Zhang YM; Huang Y; Sui S; Li XY; Abulikemu Z; Dilixiati N
Kaohsiung J Med Sci; 2021 Mar; 37(3):236-244. PubMed ID: 33089927
[TBL] [Abstract][Full Text] [Related]
12. Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts.
Wang ZF; Ma DG; Zhu Z; Mu YP; Yang YY; Feng L; Yang H; Liang JQ; Liu YY; Liu L; Lu HW
World J Gastroenterol; 2017 Dec; 23(48):8512-8525. PubMed ID: 29358859
[TBL] [Abstract][Full Text] [Related]
13. Effect of astragaloside IV against rat myocardial cell apoptosis induced by oxidative stress via mitochondrial ATP-sensitive potassium channels.
Guan FY; Yang SJ; Liu J; Yang SR
Mol Med Rep; 2015 Jul; 12(1):371-6. PubMed ID: 25739067
[TBL] [Abstract][Full Text] [Related]
14. Implication of IGF1R signaling in the protective effect of Astragaloside IV on ischemia and reperfusion-induced cardiac microvascular endothelial hyperpermeability.
He K; Yan L; Lin SQ; Liu YY; Hu BH; Chang X; Zhao XR; He SY; Wei XH; Fan JY; Pan CS; Han JY
Phytomedicine; 2022 Jun; 100():154045. PubMed ID: 35338991
[TBL] [Abstract][Full Text] [Related]
15. Effect of Combined Use of Astragaloside IV (AsIV) and Atorvastatin (AV) on Expression of PPAR-γ and Inflammation-Associated Cytokines in Atherosclerosis Rats.
Sun B; Rui R; Pan H; Zhang L; Wang X
Med Sci Monit; 2018 Sep; 24():6229-6236. PubMed ID: 30190450
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV inhibits adriamycin-induced cardiac ferroptosis by enhancing Nrf2 signaling.
Luo LF; Guan P; Qin LY; Wang JX; Wang N; Ji ES
Mol Cell Biochem; 2021 Jul; 476(7):2603-2611. PubMed ID: 33656642
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV inhibits isoprenaline‑induced cardiac fibrosis by targeting the reactive oxygen species/mitogen‑activated protein kinase signaling axis.
Dai H; Jia G; Lu M; Liang C; Wang Y; Wang H
Mol Med Rep; 2017 Apr; 15(4):1765-1770. PubMed ID: 28260010
[TBL] [Abstract][Full Text] [Related]
18. Compatibility of Tanshinone IIA and Astragaloside IV in attenuating hypoxia-induced cardiomyocytes injury.
Wang D; Liu Y; Zhong G; Wang Y; Zhang T; Zhao Z; Yan X; Liu Q
J Ethnopharmacol; 2017 May; 204():67-76. PubMed ID: 28389356
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV ameliorates cisplatin-induced liver injury by modulating ferroptosis-dependent pathways.
Guo J; Le Y; Yuan A; Liu J; Chen H; Qiu J; Wang C; Dou X; Yuan X; Lu D
J Ethnopharmacol; 2024 Jun; 328():118080. PubMed ID: 38521426
[TBL] [Abstract][Full Text] [Related]
20. [Effects of xinwei granule on STAT3 and p-STAT3 signal pathway in rats with precancerous lesion of gastric cancer].
Xie JR; Sun F; Liang GY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jan; 33(1):65-70. PubMed ID: 23596790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
